US Stock MarketDetailed Quotes

INKT MiNK Therapeutics

Watchlist
  • 8.470
  • +0.490+6.14%
Close Mar 14 16:00 ET
  • 8.470
  • 0.0000.00%
Post 16:05 ET
33.57MMarket Cap-2.29P/E (TTM)

MiNK Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
28.85%-2.99M
44.82%-2.29M
41.78%-2.54M
16.45%-15.76M
31.48%-3.04M
25.03%-4.21M
10.25%-4.15M
-4.05%-4.37M
-47.09%-18.87M
-160.27%-4.43M
Net income from continuing operations
64.69%-1.81M
56.40%-2.7M
32.94%-3.81M
19.77%-22.46M
29.75%-5.46M
19.20%-5.12M
-1.38%-6.2M
26.89%-5.69M
7.35%-27.99M
-34.79%-7.77M
Operating gains losses
--0
----
----
90.44%-266.78K
----
----
----
----
-685.00%-2.79M
----
Depreciation and amortization
17.18%62.64K
-13.11%45.1K
17.83%53.83K
68.06%204.62K
41.23%53.57K
88.02%53.45K
83.36%51.91K
68.73%45.69K
56.17%121.75K
59.15%37.93K
Other non cash items
---1.58M
--194.14K
--4.44K
----
----
----
----
----
----
----
Change In working capital
29.91%-60K
-105.84%-79.63K
75.96%620.81K
-66.95%2.9M
-51.88%1.27M
-1.38%-85.6K
-60.50%1.36M
-87.25%352.81K
134.64%8.77M
-20.71%2.63M
-Change in prepaid assets
-161.19%-136.77K
-192.78%-40.05K
36.57%-6.35K
182.71%245.59K
69.00%-11.08K
241.01%223.52K
-45.56%43.16K
94.50%-10.01K
-160.76%-296.95K
-425.02%-35.74K
-Change in payables and accrued expense
48.23%-501.69K
-197.12%-564.37K
74.73%-99.99K
-98.23%107.57K
-63.36%891.2K
-300.26%-969.15K
-56.48%581.12K
-121.57%-395.61K
2,808.98%6.09M
4,280.30%2.43M
-Change in other working capital
-12.36%578.46K
-28.92%524.78K
-4.12%727.14K
-14.57%2.54M
63.49%387.27K
261.04%660.03K
-63.72%738.26K
-32.05%758.42K
-14.23%2.98M
-92.72%236.88K
Cash from discontinued investing activities
Operating cash flow
28.85%-2.99M
44.82%-2.29M
41.78%-2.54M
16.45%-15.76M
31.48%-3.04M
25.03%-4.21M
10.25%-4.15M
-4.05%-4.37M
-47.09%-18.87M
-160.27%-4.43M
Investing cash flow
Cash flow from continuing investing activities
0
0
0
70.58%-73.56K
0
61.46%-23.04K
40.69%-37.02K
-13.5K
-0.43%-250.05K
-46,250.90%-127.84K
Net PPE purchase and sale
--0
--0
--0
70.58%-73.56K
--0
61.46%-23.04K
40.69%-37.02K
---13.5K
-0.43%-250.05K
-46,250.90%-127.84K
Cash from discontinued investing activities
Investing cash flow
--0
--0
--0
70.58%-73.56K
--0
61.46%-23.04K
40.69%-37.02K
---13.5K
-0.43%-250.05K
-46,250.90%-127.84K
Financing cash flow
Cash flow from continuing financing activities
130.52%6.81K
7,770.33%5.81M
1,597.17%5.01M
-161.68%-407.17K
-101.80%-2
497.57%2.95K
51.75%-75.7K
-48,637.74%-334.43K
-100.32%-155.6K
-100.00%111
Net issuance payments of debt
--0
--0
--5M
----
----
--0
--0
--0
----
----
Net common stock issuance
--0
6,035.45%5.8M
--0
-203.85%-477.64K
---2
--2
37.84%-97.72K
---379.92K
-100.39%-157.19K
--0
Proceeds from stock option exercised by employees
130.68%6.81K
-71.44%6.29K
-84.84%6.9K
4,317.93%70.47K
--0
497.17%2.95K
7,215.61%22.02K
6,503.19%45.5K
963.33%1.6K
--111
Cash from discontinued financing activities
Financing cash flow
130.52%6.81K
7,770.33%5.81M
1,597.17%5.01M
-161.68%-407.17K
-101.80%-2
497.57%2.95K
51.75%-75.7K
-48,637.74%-334.43K
-100.32%-155.6K
-100.00%111
Net cash flow
Beginning cash position
-12.32%9.31M
-60.94%5.82M
-82.85%3.37M
-49.51%19.64M
-73.51%6.4M
-64.41%10.62M
-57.07%14.89M
-49.51%19.64M
1,345.06%38.89M
2,848.15%24.16M
Current changes in cash
29.35%-2.99M
182.45%3.52M
152.28%2.46M
15.72%-16.24M
33.40%-3.04M
25.46%-4.23M
11.99%-4.26M
-12.36%-4.71M
-153.27%-19.27M
-111.97%-4.56M
Effect of exchange rate changes
-54.48%2.69K
-210.58%-19.02K
49.43%-14.84K
-230.26%-25.25K
-87.82%4.31K
141.32%5.91K
-313.01%-6.12K
-539.77%-29.34K
14.71%19.39K
236.54%35.39K
End cash Position
-1.10%6.33M
-12.32%9.31M
-60.94%5.82M
-82.85%3.37M
-82.85%3.37M
-73.51%6.4M
-64.41%10.62M
-57.07%14.89M
-49.51%19.64M
-49.51%19.64M
Free cash flow
29.23%-2.99M
45.30%-2.29M
41.96%-2.54M
17.16%-15.84M
33.40%-3.04M
25.42%-4.23M
10.66%-4.19M
-4.37%-4.38M
-46.20%-19.12M
-167.82%-4.56M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 28.85%-2.99M44.82%-2.29M41.78%-2.54M16.45%-15.76M31.48%-3.04M25.03%-4.21M10.25%-4.15M-4.05%-4.37M-47.09%-18.87M-160.27%-4.43M
Net income from continuing operations 64.69%-1.81M56.40%-2.7M32.94%-3.81M19.77%-22.46M29.75%-5.46M19.20%-5.12M-1.38%-6.2M26.89%-5.69M7.35%-27.99M-34.79%-7.77M
Operating gains losses --0--------90.44%-266.78K-----------------685.00%-2.79M----
Depreciation and amortization 17.18%62.64K-13.11%45.1K17.83%53.83K68.06%204.62K41.23%53.57K88.02%53.45K83.36%51.91K68.73%45.69K56.17%121.75K59.15%37.93K
Other non cash items ---1.58M--194.14K--4.44K----------------------------
Change In working capital 29.91%-60K-105.84%-79.63K75.96%620.81K-66.95%2.9M-51.88%1.27M-1.38%-85.6K-60.50%1.36M-87.25%352.81K134.64%8.77M-20.71%2.63M
-Change in prepaid assets -161.19%-136.77K-192.78%-40.05K36.57%-6.35K182.71%245.59K69.00%-11.08K241.01%223.52K-45.56%43.16K94.50%-10.01K-160.76%-296.95K-425.02%-35.74K
-Change in payables and accrued expense 48.23%-501.69K-197.12%-564.37K74.73%-99.99K-98.23%107.57K-63.36%891.2K-300.26%-969.15K-56.48%581.12K-121.57%-395.61K2,808.98%6.09M4,280.30%2.43M
-Change in other working capital -12.36%578.46K-28.92%524.78K-4.12%727.14K-14.57%2.54M63.49%387.27K261.04%660.03K-63.72%738.26K-32.05%758.42K-14.23%2.98M-92.72%236.88K
Cash from discontinued investing activities
Operating cash flow 28.85%-2.99M44.82%-2.29M41.78%-2.54M16.45%-15.76M31.48%-3.04M25.03%-4.21M10.25%-4.15M-4.05%-4.37M-47.09%-18.87M-160.27%-4.43M
Investing cash flow
Cash flow from continuing investing activities 00070.58%-73.56K061.46%-23.04K40.69%-37.02K-13.5K-0.43%-250.05K-46,250.90%-127.84K
Net PPE purchase and sale --0--0--070.58%-73.56K--061.46%-23.04K40.69%-37.02K---13.5K-0.43%-250.05K-46,250.90%-127.84K
Cash from discontinued investing activities
Investing cash flow --0--0--070.58%-73.56K--061.46%-23.04K40.69%-37.02K---13.5K-0.43%-250.05K-46,250.90%-127.84K
Financing cash flow
Cash flow from continuing financing activities 130.52%6.81K7,770.33%5.81M1,597.17%5.01M-161.68%-407.17K-101.80%-2497.57%2.95K51.75%-75.7K-48,637.74%-334.43K-100.32%-155.6K-100.00%111
Net issuance payments of debt --0--0--5M----------0--0--0--------
Net common stock issuance --06,035.45%5.8M--0-203.85%-477.64K---2--237.84%-97.72K---379.92K-100.39%-157.19K--0
Proceeds from stock option exercised by employees 130.68%6.81K-71.44%6.29K-84.84%6.9K4,317.93%70.47K--0497.17%2.95K7,215.61%22.02K6,503.19%45.5K963.33%1.6K--111
Cash from discontinued financing activities
Financing cash flow 130.52%6.81K7,770.33%5.81M1,597.17%5.01M-161.68%-407.17K-101.80%-2497.57%2.95K51.75%-75.7K-48,637.74%-334.43K-100.32%-155.6K-100.00%111
Net cash flow
Beginning cash position -12.32%9.31M-60.94%5.82M-82.85%3.37M-49.51%19.64M-73.51%6.4M-64.41%10.62M-57.07%14.89M-49.51%19.64M1,345.06%38.89M2,848.15%24.16M
Current changes in cash 29.35%-2.99M182.45%3.52M152.28%2.46M15.72%-16.24M33.40%-3.04M25.46%-4.23M11.99%-4.26M-12.36%-4.71M-153.27%-19.27M-111.97%-4.56M
Effect of exchange rate changes -54.48%2.69K-210.58%-19.02K49.43%-14.84K-230.26%-25.25K-87.82%4.31K141.32%5.91K-313.01%-6.12K-539.77%-29.34K14.71%19.39K236.54%35.39K
End cash Position -1.10%6.33M-12.32%9.31M-60.94%5.82M-82.85%3.37M-82.85%3.37M-73.51%6.4M-64.41%10.62M-57.07%14.89M-49.51%19.64M-49.51%19.64M
Free cash flow 29.23%-2.99M45.30%-2.29M41.96%-2.54M17.16%-15.84M33.40%-3.04M25.42%-4.23M10.66%-4.19M-4.37%-4.38M-46.20%-19.12M-167.82%-4.56M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion--

Trending Stocks

U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Micron Technology
MU
100.790
NVIDIA
NVDA
121.670
Adobe
ADBE
394.740
4
Tesla
TSLA
249.980
5
Netflix
NFLX
918.000
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Trump's comeback to the Office
Following Trump's Policies to Seek Investment Opportunities
Discussing
Tesla's earnings caused fluctuations, what's your market outlook？
Tesla's Q4 2024 revenue was $25.71 billion, up 2% year-on-year but below expectations. Can Tesla's stock price keep rising in 2025 with Trum Show More
TSLA earnings preview: Grab rewards by guessing the opening price!